Literature DB >> 3680036

Inhibition of tyrosine protein kinase by synthetic erbstatin analogs.

K Isshiki1, M Imoto, T Sawa, K Umezawa, T Takeuchi, H Umezawa, T Tsuchida, T Yoshioka, K Tatsuta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3680036     DOI： 10.7164/antibiotics.40.1209

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  5 in total

1.  QSAR of conformationally flexible molecules: comparative molecular field analysis of protein-tyrosine kinase inhibitors.

Authors:  M C Nicklaus; G W Milne; T R Burke
Journal:  J Comput Aided Mol Des       Date:  1992-10       Impact factor: 3.686

Review 2.  Professor Hamao Umezawa opened up a new road for the development of molecularly targeted therapeutic drugs for cancers.

Authors:  Masaya Imoto
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

3.  Calcium-dependent activation of Erk-1 and Erk-2 after hypo-osmotic astrocyte swelling.

Authors:  F Schliess; R Sinning; R Fischer; C Schmalenbach; D Häussinger
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

4.  Piracy of decay-accelerating factor (CD55) signal transduction by the diffusely adhering strain Escherichia coli C1845 promotes cytoskeletal F-actin rearrangements in cultured human intestinal INT407 cells.

Authors:  I Peiffer; A L Servin; M F Bernet-Camard
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  Inhibition of human neutrophil responses by alpha-cyano-3,4-dihydroxythiocinnamamide; a protein-tyrosine kinase inhibitor.

Authors:  P Dryden; V Duronio; L Martin; A T Hudson; H Salari
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.